Page last updated: 2024-08-17

tetrabenazine and Chronic Motor and Vocal Tic Disorder

tetrabenazine has been researched along with Chronic Motor and Vocal Tic Disorder in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19909 (33.33)18.7374
1990's0 (0.00)18.2507
2000's7 (25.93)29.6817
2010's7 (25.93)24.3611
2020's4 (14.81)2.80

Authors

AuthorsStudies
Gros, Y; Schuldiner, S; Segal, T; Ugolev, Y; Yaffe, D1
Alexander, J; Barkay, H; Claassen, DO; Coffey, B; Garofalo, EA; Gertz, BJ; Gordon, MF; Harary, E; Jankovic, J; Jimenez-Shahed, J; Savola, JM; Stamler, DA; Wieman, M1
Alexander, JK; Barkay, H; Claassen, DO; Coffey, B; Garofalo, EA; Gertz, BJ; Gordon, MF; Harary, E; Jankovic, J; Jimenez-Shahed, J; Savola, JM; Stamler, DA; Wieman, M1
Jankovic, J; Makhoul, K1
Angelov, A; Carmack, T; Farber, RH; Kim, K; Roberts, E; Thai-Cuarto, D1
Paton, DM1
Kim, ES1
Jankovic, J; Niemann, N1
Hajjar, M; Poulopoulos, M1
Brambilla, A; Cavallazzi, M; Fornari, M; Porta, M; Sassi, M; Servello, D1
Albin, RL; Frey, KA; Kilbourn, MR; Koeppe, RA; Nichols, T; Wernette, K; Zhuang, W1
Akdeniz, M; Yaman, A; Yaman, H1
Davidson, A; Hunter, C; Jankovic, J; Jimenez-Shahed, J; Mehanna, R1
Bruneau, MA; Chouinard, S; Lespérance, P1
Sandor, P1
Albin, RL; Bohnen, NI; Frey, KA; Kilbourn, MR; Koeppe, RA; Meyer, P; Minoshima, S; Nichols, TE; Wernette, K1
Apter, A; Ben-Dor, DH; Rehavi, M; Roz, N; Sever, J; Weizman, A; Zimmerman, S1
Davis, A; Jong, D; Ondo, WG1
Frost, JD; Glaze, DG; Jankovic, J2
Jankovic, J1
Fog, R; Pakkenberg, B; Pakkenberg, H; Regeur, L2
Jankovic, J; Singh, SK1
Vieregge, P1
Marsden, CD1
Bruun, R; Shapiro, AK; Shapiro, E; Sweet, RD1

Reviews

7 review(s) available for tetrabenazine and Chronic Motor and Vocal Tic Disorder

ArticleYear
Clinical development of valbenazine for tics associated with Tourette syndrome.
    Expert review of neurotherapeutics, 2021, Volume: 21, Issue:4

    Topics: Adult; Antipsychotic Agents; Child; Humans; Tetrabenazine; Tics; Tourette Syndrome; Valine; Vesicular Monoamine Transport Proteins

2021
Deutetrabenazine: Treatment of hyperkinetic aspects of Huntington's disease, tardive dyskinesia and Tourette syndrome.
    Drugs of today (Barcelona, Spain : 1998), 2017, Volume: 53, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Animals; Drug Approval; Heart Rate; Humans; Huntington Disease; Hyperkinesis; Molecular Structure; Motor Activity; Structure-Activity Relationship; Tardive Dyskinesia; Tetrabenazine; Tourette Syndrome; Treatment Outcome; United States; United States Food and Drug Administration

2017
Valbenazine: First Global Approval.
    Drugs, 2017, Volume: 77, Issue:10

    Topics: Adult; Clinical Trials as Topic; Drug Approval; Humans; Tardive Dyskinesia; Tetrabenazine; Tourette Syndrome; United States; United States Food and Drug Administration; Valine; Vesicular Monoamine Transport Proteins

2017
Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.
    Drugs, 2018, Volume: 78, Issue:5

    Topics: Antipsychotic Agents; Drug Approval; Humans; Huntington Disease; Tardive Dyskinesia; Tetrabenazine; Tourette Syndrome; United States; United States Food and Drug Administration; Valine; Vesicular Monoamine Transport Proteins

2018
Tourette's syndrome and role of tetrabenazine: review and personal experience.
    Clinical drug investigation, 2008, Volume: 28, Issue:7

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Clinical Trials as Topic; Female; Humans; Longitudinal Studies; Male; Prospective Studies; Psychometrics; Severity of Illness Index; Tetrabenazine; Tourette Syndrome; Treatment Outcome

2008
How best to address these common movement disorders.
    The Journal of family practice, 2011, Volume: 60, Issue:12

    Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Anticonvulsants; Antiparkinson Agents; Essential Tremor; Humans; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Parkinson Disease; Practice Guidelines as Topic; Primidone; Propranolol; Tetrabenazine; Tourette Syndrome; Treatment Outcome

2011
Pharmacological management of tics in patients with TS.
    Journal of psychosomatic research, 2003, Volume: 55, Issue:1

    Topics: Anti-Dyskinesia Agents; Antipsychotic Agents; Clonidine; Dopamine Antagonists; Haloperidol; Humans; Practice Guidelines as Topic; Sympatholytics; Tetrabenazine; Tics; Tourette Syndrome

2003

Trials

5 trial(s) available for tetrabenazine and Chronic Motor and Vocal Tic Disorder

ArticleYear
Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial.
    JAMA network open, 2021, 10-01, Volume: 4, Issue:10

    Topics: Adolescent; Adolescent Behavior; Child; Double-Blind Method; Female; Humans; Male; Patient Safety; Tetrabenazine; Tourette Syndrome; Treatment Outcome

2021
Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial.
    JAMA network open, 2021, 10-01, Volume: 4, Issue:10

    Topics: Adolescent; Child; Double-Blind Method; Female; Humans; Male; Pediatrics; Tetrabenazine; Tics; Tourette Syndrome; Treatment Outcome

2021
Tourette's syndrome and role of tetrabenazine: review and personal experience.
    Clinical drug investigation, 2008, Volume: 28, Issue:7

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Clinical Trials as Topic; Female; Humans; Longitudinal Studies; Male; Prospective Studies; Psychometrics; Severity of Illness Index; Tetrabenazine; Tourette Syndrome; Treatment Outcome

2008
Comparison of weight gain in treatments for Tourette syndrome: tetrabenazine versus neuroleptic drugs.
    Journal of child neurology, 2008, Volume: 23, Issue:4

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Antipsychotic Agents; Child; Female; Humans; Male; Tetrabenazine; Tourette Syndrome; Weight Gain

2008
Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Effects of alpha methyl para tyrosine and tetrabenazine.
    Archives of general psychiatry, 1974, Volume: 31, Issue:6

    Topics: Adolescent; Adult; Benztropine; Brain; Brain Chemistry; Catecholamines; Clinical Trials as Topic; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Male; Methyltyrosines; Physostigmine; Placebos; Receptors, Drug; Remission, Spontaneous; Scopolamine; Tetrabenazine; Tourette Syndrome

1974

Other Studies

16 other study(ies) available for tetrabenazine and Chronic Motor and Vocal Tic Disorder

ArticleYear
Identification of conformationally sensitive residues essential for inhibition of vesicular monoamine transport by the noncompetitive inhibitor tetrabenazine.
    The Journal of biological chemistry, 2013, Nov-08, Volume: 288, Issue:45

    Topics: Adrenergic Uptake Inhibitors; Animals; Binding Sites; Biological Transport, Active; HEK293 Cells; Humans; Huntington Disease; Mutagenesis, Site-Directed; Protein Structure, Secondary; Rats; Saccharomyces cerevisiae; Tetrabenazine; Tourette Syndrome; Vesicular Monoamine Transport Proteins

2013
Real-world experience with VMAT2 inhibitors in Tourette syndrome.
    Journal of neurology, 2023, Volume: 270, Issue:9

    Topics: Drug-Related Side Effects and Adverse Reactions; Humans; Retrospective Studies; Tardive Dyskinesia; Tetrabenazine; Tics; Tourette Syndrome; United States; Vesicular Monoamine Transport Proteins

2023
Post-traumatic tics and tetrabenazine treatment: a blinded video assessment.
    BMJ case reports, 2013, Dec-05, Volume: 2013

    Topics: Accidents, Traffic; Adrenergic Uptake Inhibitors; Craniocerebral Trauma; Humans; Male; Severity of Illness Index; Tetrabenazine; Tourette Syndrome

2013
Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome.
    Neurology, 2009, Apr-21, Volume: 72, Issue:16

    Topics: Adolescent; Adult; Binding, Competitive; Carbon Radioisotopes; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Humans; Male; Methylphenidate; Middle Aged; Positron-Emission Tomography; Presynaptic Terminals; Substantia Nigra; Tetrabenazine; Tourette Syndrome; Vesicular Monoamine Transport Proteins; Young Adult

2009
Analysis of CYP2D6 genotype and response to tetrabenazine.
    Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:2

    Topics: Adult; Anti-Dyskinesia Agents; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Huntington Disease; Hyperkinesis; Male; Middle Aged; Movement Disorders; Myoclonus; Pharmacogenetics; Phenotype; Psychomotor Agitation; Tetrabenazine; Tourette Syndrome; Treatment Outcome

2013
Catastrophic reactions induced by tetrabenazine.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2002, Volume: 47, Issue:7

    Topics: Adult; Anti-Dyskinesia Agents; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Dystonia; Female; Humans; Male; Middle Aged; Tetrabenazine; Tourette Syndrome

2002
Increased ventral striatal monoaminergic innervation in Tourette syndrome.
    Neurology, 2003, Aug-12, Volume: 61, Issue:3

    Topics: Adolescent; Adult; Binding, Competitive; Biogenic Monoamines; Body Fluid Compartments; Carbon Radioisotopes; Corpus Striatum; Female; Humans; Image Processing, Computer-Assisted; Ligands; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Models, Biological; Neurons; Neuropeptides; Presynaptic Terminals; Reference Values; Tetrabenazine; Tomography, Emission-Computed; Tourette Syndrome; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins

2003
Reduced platelet vesicular monoamine transporter density in Tourette's syndrome pediatric male patients.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2007, Volume: 17, Issue:8

    Topics: Adolescent; Blood Platelets; Cell Membrane; Child; Humans; Ligands; Male; Radiopharmaceuticals; Tetrabenazine; Tourette Syndrome; Vesicular Monoamine Transport Proteins

2007
Sleep in Gilles de la Tourette's syndrome: disorder of arousal.
    Neurology, 1983, Volume: 33, Issue:5

    Topics: Adolescent; Adult; Arousal; Behavior; Child; Electroencephalography; Female; Humans; Male; Middle Aged; Sleep Wake Disorders; Tetrabenazine; Tourette Syndrome

1983
Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Advances in neurology, 1983, Volume: 37

    Topics: Adolescent; Adult; Aged; Child; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Hyperkinesis; Male; Middle Aged; Movement Disorders; Myoclonus; Outcome and Process Assessment, Health Care; Syndrome; Tetrabenazine; Tourette Syndrome

1983
Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome.
    Neurology, 1984, Volume: 34, Issue:5

    Topics: Adolescent; Adult; Child; Female; Humans; Male; Middle Aged; Receptors, Dopamine; Sleep; Sleep Stages; Tetrabenazine; Tic Disorders; Tourette Syndrome

1984
[Gilles de la Tourette's syndrome. Experiences with 18 patients].
    Ugeskrift for laeger, 1982, Oct-18, Volume: 144, Issue:42

    Topics: Adolescent; Adult; Child; Clonidine; Female; Humans; Male; Pimozide; Tetrabenazine; Tourette Syndrome

1982
Tardive dystonia in patients with Tourette's syndrome.
    Movement disorders : official journal of the Movement Disorder Society, 1988, Volume: 3, Issue:3

    Topics: Adult; Antipsychotic Agents; Dystonia; Humans; Male; Tetrabenazine; Tourette Syndrome

1988
Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome.
    Journal of neurology, neurosurgery, and psychiatry, 1986, Volume: 49, Issue:7

    Topics: Adolescent; Adult; Child; Clonidine; Drug Therapy, Combination; Electroencephalography; Female; Humans; Male; Middle Aged; Pimozide; Tetrabenazine; Tomography, X-Ray Computed; Tourette Syndrome

1986
Tetrabenazine in the treatment of senile vocal tics.
    Journal of neurology, 1987, Volume: 235, Issue:2

    Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Humans; Movement Disorders; Tetrabenazine; Tic Disorders; Tourette Syndrome; Voice Disorders

1987
Drug treatment of diseases characterized by abnormal movements.
    Proceedings of the Royal Society of Medicine, 1973, Volume: 66, Issue:9

    Topics: Chorea; Diazepam; Ethanol; Haloperidol; Humans; Huntington Disease; Levodopa; Movement Disorders; Myoclonus; Phenothiazines; Propranolol; Reserpine; Tetrabenazine; Tic Disorders; Torticollis; Tourette Syndrome; Tremor

1973